220 related articles for article (PubMed ID: 30238177)
1. Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases.
Kasoha M; Bohle RM; Seibold A; Gerlinger C; Juhasz-Böss I; Solomayer EF
Clin Exp Metastasis; 2018 Dec; 35(8):763-775. PubMed ID: 30238177
[TBL] [Abstract][Full Text] [Related]
2. The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases.
Mariz K; Ingolf JB; Daniel H; Teresa NJ; Erich-Franz S
Clin Exp Metastasis; 2015 Dec; 32(8):857-66. PubMed ID: 26420587
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases.
Bu G; Lu W; Liu CC; Selander K; Yoneda T; Hall C; Keller ET; Li Y
Int J Cancer; 2008 Sep; 123(5):1034-42. PubMed ID: 18546262
[TBL] [Abstract][Full Text] [Related]
4. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types.
Forget MA; Turcotte S; Beauseigle D; Godin-Ethier J; Pelletier S; Martin J; Tanguay S; Lapointe R
Br J Cancer; 2007 Feb; 96(4):646-53. PubMed ID: 17245340
[TBL] [Abstract][Full Text] [Related]
5. Correlations of DKK1 with incidence and prognosis of breast cancer.
Sun W; Shang J; Zhang J; Chen S; Hao M
J BUON; 2019; 24(1):26-32. PubMed ID: 30941948
[TBL] [Abstract][Full Text] [Related]
6. Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype.
Xu WH; Liu ZB; Yang C; Qin W; Shao ZM
PLoS One; 2012; 7(5):e37624. PubMed ID: 22649545
[TBL] [Abstract][Full Text] [Related]
7. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1.
Zhuang X; Zhang H; Li X; Li X; Cong M; Peng F; Yu J; Zhang X; Yang Q; Hu G
Nat Cell Biol; 2017 Oct; 19(10):1274-1285. PubMed ID: 28892080
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels.
Granchi D; Corrias MV; Garaventa A; Baglìo SR; Cangemi G; Carlini B; Paolucci P; Giunti A; Baldini N
Bone; 2011 Jan; 48(1):152-9. PubMed ID: 20603237
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer.
Hong SA; Yoo SH; Lee HH; Sun S; Won HS; Kim O; Ko YH
BMC Cancer; 2018 May; 18(1):506. PubMed ID: 29720122
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiation.
Chu T; Teng J; Jiang L; Zhong H; Han B
Biochem Biophys Res Commun; 2014 Jan; 443(3):962-8. PubMed ID: 24361889
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk of estrogen receptors and Wnt/β-catenin signaling in endometrial cancer.
Kasoha M; Dernektsi C; Seibold A; Bohle RM; Takacs Z; Ioan-Iulian I; Solomayer EF; Juhasz-Böss I
J Cancer Res Clin Oncol; 2020 Feb; 146(2):315-327. PubMed ID: 31865530
[TBL] [Abstract][Full Text] [Related]
12. Serum Dickkopf-1 acts as a new biomarker in human breast cancer.
Liu JT; Guo WB; Sun JY
Minerva Med; 2017 Aug; 108(4):334-340. PubMed ID: 28248066
[TBL] [Abstract][Full Text] [Related]
13. DKK1 promotes migration and invasion of non-small cell lung cancer via β-catenin signaling pathway.
Zhang J; Zhang X; Zhao X; Jiang M; Gu M; Wang Z; Yue W
Tumour Biol; 2017 Jul; 39(7):1010428317703820. PubMed ID: 28677426
[TBL] [Abstract][Full Text] [Related]
14. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of Dickkopf-1 are associated with β-catenin accumulation and poor prognosis in patients with chondrosarcoma.
Chen C; Zhou H; Zhang X; Ma X; Liu Z; Liu X
PLoS One; 2014; 9(8):e105414. PubMed ID: 25144498
[TBL] [Abstract][Full Text] [Related]
16. Dickkopf-1 as a mediator and novel target in malignant bone disease.
Rachner TD; Göbel A; Benad-Mehner P; Hofbauer LC; Rauner M
Cancer Lett; 2014 May; 346(2):172-7. PubMed ID: 24462802
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the Wnt-β-catenin signalling antagonists, sclerostin and dickkopf-related protein 1, in chronic periodontitis.
Napimoga MH; Nametala C; da Silva FL; Miranda TS; Bossonaro JP; Demasi AP; Duarte PM
J Clin Periodontol; 2014 Jun; 41(6):550-7. PubMed ID: 24576302
[TBL] [Abstract][Full Text] [Related]
18. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.
Sato N; Yamabuki T; Takano A; Koinuma J; Aragaki M; Masuda K; Ishikawa N; Kohno N; Ito H; Miyamoto M; Nakayama H; Miyagi Y; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Cancer Res; 2010 Jul; 70(13):5326-36. PubMed ID: 20551066
[TBL] [Abstract][Full Text] [Related]
19. Increased Dickkopf-1 expression in breast cancer bone metastases.
Voorzanger-Rousselot N; Goehrig D; Journe F; Doriath V; Body JJ; Clézardin P; Garnero P
Br J Cancer; 2007 Oct; 97(7):964-70. PubMed ID: 17876334
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Otterson MF; Behmaram B; Gockel I; Mackinnon A; Shaker R
Neoplasia; 2015 Jul; 17(7):598-611. PubMed ID: 26297437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]